2009
DOI: 10.1080/02652040802365182
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterion

Abstract: Dextran sulphate can significantly increase AG incorporation into the chitosan nanoparticles. The concentration of each component was critical in preparing AG-loaded chitosan nanoparticles. The chitosan nanoparticles designed in this study may provide a promising oral drug delivery formulation for AG which usually, in tuberculosis treatment, is administrated as an injectible preparation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
48
1

Year Published

2009
2009
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(52 citation statements)
references
References 23 publications
3
48
1
Order By: Relevance
“…Daily administration of chitosan-coated streptomycin/dextran sulfate complexes for 3 weeks decreases 15% bacterial levels; the same result obtained for similar schedule of subcutaneous administration of free drug (Lu et al, 2009) Gelatin Rifampicin Nanoparticles Mice Intravenous…”
Section: Guinea Pigs Pulmonarysupporting
confidence: 54%
See 1 more Smart Citation
“…Daily administration of chitosan-coated streptomycin/dextran sulfate complexes for 3 weeks decreases 15% bacterial levels; the same result obtained for similar schedule of subcutaneous administration of free drug (Lu et al, 2009) Gelatin Rifampicin Nanoparticles Mice Intravenous…”
Section: Guinea Pigs Pulmonarysupporting
confidence: 54%
“…In one case, chitosan-coated complexes of streptomycin and dextran sulfate (500 nm) (Lu et al, 2009). The efficacy of the formulation is substantially lower than that observed for alginate formulations presented before and, unfortunately, controls such as the oral administration of free drug, for instance, were not reported.…”
Section: Polymeric Nanoparticlesmentioning
confidence: 94%
“…Gentamicin have been previously examined in a wide variety of nanoparticle delivery systems, including poly(lactide-co-glycolide) (PLGA), chitosan, and caroboxymethyldextran-b-poly(ethyleneglycols). [12][13][14] The application of antibiotic nanoparticle formulations has been shown to offer several advantages over conventional administration and delivery methods, including the ability for drug delivery to a specific site such as an intracellular infection. 15,16 Nanoparticles can also be exploited to facilitate sustained release of an antibiotic, minimizing dosing regimens.…”
Section: Introductionmentioning
confidence: 99%
“…18 Moreover, polymeric nanoparticles have shown to enhance the oral bioavailability of orally inactive antibiotics. 13 PLGA polymers have been used to entrap several antibiotics in nanoparticle formulations, demonstrating improved delivery and antibiotic efficacy. [19][20][21] Although encapsulation and the biological usefulness of gentamicin in PLGA have been previously reported, encapsulation efficiencies have been modest.…”
Section: Introductionmentioning
confidence: 99%
“…Due to its biocompatibility, biodegradability and non-toxicity, chitosan has increasingly been used in the biomedical and pharmaceutical fields [1][2][3][4]. Chemical modifications have been used to prepare chitosan derivatives with enhanced biological and physicochemical properties.…”
Section: Introductionmentioning
confidence: 99%